CurrentUnitedHealthcarePolicy CS097.R

Pneumatic Compression Devices

UnitedHealthcare medical policy defining clinical coverage rationale, evidence summaries, and applicable HCPCS codes for pneumatic compression devices (including advanced APCDs) for indications such as lymphedema (head/neck), peripheral arterial disease (PAD), chronic venous insufficiency (CVI) with non-healing lower extremity ulcers, and DVT prevention; references InterQual clinical criteria for specific medical necessity determinations.

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices

Policy CodePolicy CS097.R

Change TypeRevised coverage rationale; documentation and references updated

Effective DateJuly 1, 2025

Next Review Date

Key ActionRefer to and meet the InterQual CP: Durable Medical Equipment; Pneumatic and other Powered Compression Devices clinical criteria and be prepared to supply medical records documentation for coverage review.

POLICY UPDATE CHANGES

Coverage rationale language changed to replace 'proven and medically necessary in an outpatient setting or upon discharge from an inpatient setting for the prevention of DVT' with 'proven and medically necessary in certain circumstances for the prevention of DVT'.

Added medical records documentation language indicating benefit coverage is determined by federal, state, or contractual requirements and that documentation may be required for review.

Clinical Evidence and References sections updated to reflect most current information; prior policy version archived (CS097.Q).

18HCPCS Codes Listed

3Primary Indication Categories Discussed

Coverage Summary

This policy addresses pneumatic compression devices (PCDs) — devices combining a compressor and garments that sequentially inflate and deflate — for several clinical indications. Key covered/positioned indications include treatment of lymphedema and chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers, while PCDs for peripheral arterial disease (PAD) (high-pressure/rapid-inflation devices) and advanced head/neck APCDs are considered unproven / not medically necessary for some uses.

Intermittent limb compression devices are recognized as proven and medically necessary in certain circumstances for prevention of deep venous thrombosis (DVT); specific medical necessity criteria for treatment indications (lymphedema, CVI, DVT prevention) are defined by and require reference to the InterQual clinical criteria (InterQual CP: Durable Medical Equipment; Pneumatic and other Powered Compression Devices).

For regulatory context, pneumatic compression devices are FDA Class II devices (product code JOW); FDA clearance (e.g., Flexitouch Plus) is informational and not by itself a basis for coverage determinations.

Benefit coverage determinations may be subject to federal, state, or contractual requirements and medical records/documentation may be requested during review; documentation does not guarantee coverage.

Key facts

Policy NumberCS097.R

Effective DateJuly 1, 2025

StatusCURRENT

Primary indications discussed3 categories (lymphedema head/neck; PAD; CVI with edema and non-healing lower extremity ulcers; plus DVT prevention referenced)

DVT prevention coverage noteCoverage for DVT prevention is conditional — IPC devices are proven and medically necessary in certain circumstances; medical necessity criteria per InterQual must be met

Reference to InterQualInterQual CP: Durable Medical Equipment; Pneumatic and other Powered Compression Devices governs clinical criteria

HCPCS codes listed (count)18 codes referenced (see Applicable Codes section)

Medical-Necessity Criteria

Coverage Rationale - Summary Statements

Policy-level coverage positions:

APCD head/neck: Advanced intermittent pneumatic compression devices (e.g., Flexitouch) for treating lymphedema of the head, face, or neck are considered unproven and not medically necessary.
HPIPC for PAD: Pneumatic compression devices (high pressure; rapid inflation/deflation cycle) for treating peripheral arterial disease (PAD) are considered unproven and not medically necessary.
IPC proven in certain circumstances: Pneumatic compression devices are proven and medically necessary in certain circumstances for the treatment of lymphedema or chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers; for medical necessity clinical coverage criteria, refer to the InterQual CP: Durable Medical Equipment; Pneumatic and other Powered Compression Devices.

Coding

Device regulation / informational codesmixed

JOW	FDA product code for pneumatic compression devices (informational)

Provider Actions / Prior Authorization & Documentation

Prior Authorization

Refer to InterQual criteria for medical necessity

Determinations for coverage of pneumatic compression devices for lymphedema, chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers, and for prevention of deep venous thrombosis (DVT) are based on InterQual CP: Durable Medical Equipment; Pneumatic and other Powered Compression Devices clinical criteria. Prior authorization or clinical review may be required and approval is contingent on meeting the InterQual medical-necessity criteria.

InterQual CP criteria must be met for lymphedema coverage decisions.
InterQual CP criteria must be met for CVI with edema and non-healing lower extremity ulcers coverage decisions.
InterQual CP criteria must be met for DVT prevention coverage decisions.
Prior authorization or clinical review may be required; coverage is contingent on meeting InterQual criteria.

Background and Evidence Summary

Pneumatic compression devices (PCDs) consist of an air compressor unit attached to one or more garments that sequentially inflate and deflate to apply pressure against the skin and underlying tissues.

Devices range from simple intermittent pneumatic compression (IPC) sleeves (single- or multi-chambered inflatable leg sleeves used for VTE prophylaxis and edema control) to more complex, programmable advanced pneumatic compression devices (APCDs) with multiple garment options and treatment programs intended to address fibrosis, head/neck or trunk edema, chronic wounds, or localized swelling.

Representative HCPCS device and appliance codes (for reference) include compressor and garment codes (e.g., E0650–E0676; A4600) and specific codes for high-pressure arterial systems (e.g., E0675).

Study/Source	Key finding
CLOTS3 (Dennis et al., CLOTS 3 trial / Health Technology Assessment)	IPC reduced DVT in immobile stroke patients: primary outcome 12.1%→8.5% (absolute reduction 3.6%); adjusted OR 0.65; improved 6‑month survival (HR 0.86). IPC applied up to 30 days or until discharge/walking independently.
Achilles tendon RCT (Domeij‑Arverud et al., 2015)	Outpatient post‑op immobilized patients: IPC 6 hrs/day for 2 weeks reduced DVT at 2 weeks (21% vs 37%, p=0.042); effect not sustained at 6 weeks after stopping IPC.
Ridner et al. (2021) RCT (Flexitouch APCD for head/neck lymphedema)	Pilot randomized wait‑list trial showed feasibility, safety, improved perceived control and reduced visible external swelling; adherence issues with prescribed twice‑daily use; no serious device‑related adverse events.
Hayes (Evolving Evidence Review, Flexitouch; 2021 updated 2023)	Limited evidence / minimal support for Flexitouch Plus for head and neck lymphedema: small studies, short follow‑up, nonvalidated measures; no guideline specifically endorsing Flexitouch alone.
ECRI (2021 Clinical Evidence Assessment on IPC for PAD)	Inconsistent evidence for IPC in PAD/CLI: may improve walking distance, wound healing and limb salvage in some studies but overall high risk of bias and insufficient evidence; consider IPC when revascularization not possible.
Cochrane (Kakkos et al., 2022)	Combined IPC plus pharmacologic prophylaxis reduced pulmonary embolism vs pharmacologic alone (OR 0.46; low‑certainty evidence across surgical/trauma studies).
Systematic reviews / meta‑analyses (multiple sources: Kim 2024; Herring 2023; Zhang 2018; O'Connell 2016)	Mixed evidence: IPC may be comparable to anticoagulation for major outcomes, may lower bleeding vs anticoagulation, and may reduce DVT vs no prophylaxis; quality and heterogeneity of trials limit conclusions; combination therapy sometimes favored.

Definitions

APCD: Advanced pneumatic compression device (examples: systems designed to treat head/neck or other complex lymphedema regions).

IPC / IPCD: Intermittent pneumatic compression or intermittent pneumatic compression device — inflatable sleeves or garments that sequentially compress limbs and are used for edema management and mechanical VTE prophylaxis.

HPIPC / HPILC: High-pressure intermittent pneumatic compression / high-pressure intermittent limb compression — higher-pressure, rapid inflation/deflation systems used investigationally for peripheral arterial disease (PAD).

IPC (term entry): Intermittent limb compression devices — inflatable sleeves (wrapped and secured, often with Velcro) that are inflated sequentially (distal to proximal or at intervals) to reduce venous stasis and stimulate intrinsic fibrinolytic factors; used for DVT prevention and edema/venous ulcer management.

Revision History

2025-07-01material_changeLatest

Coverage rationale language narrowed: replaced 'intermittent limb compression devices are proven and medically necessary in an outpatient setting or upon discharge from an inpatient setting for the prevention of deep venous thrombosis (DVT)' with 'intermittent limb compression devices are proven and medically necessary in certain circumstances for the prevention of DVT'.

2025-07-01added

Medical records documentation language added stating benefit coverage is determined by federal, state, or contractual requirements and that medical records documentation may be required for review but does not guarantee coverage.

2025-07-01